Wai Yuen Tong Medicine Holdings Limited (HKG:0897)

HKG:0897 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	96.28	154.97	525.87	510.15	507.23	475.7
Short-Term Investments	0.37	8.13	0.81	19.84	47.94	48.12
Trading Asset Securities	12.26	28.75	41.76	99.76	98.74	50.46
Cash & Short-Term Investments	108.9	191.85	568.44	629.74	653.92	574.28
Cash Growth	-78.25%	-66.25%	-9.73%	-3.70%	13.87%	-36.42%
Accounts Receivable	86.46	81.36	68.03	63.35	53.3	67.3
Other Receivables	0.18	35.57	93.98	69.52	137.01	120.95
Receivables	102.57	216.92	195.32	176.14	242.27	238.92
Inventory	275.53	308.1	1,637	1,869	2,118	2,097
Prepaid Expenses	65.43	12.08	52.28	31.61	30.42	25.79
Restricted Cash	-	-	12.17	7.31	22.3	8.16
Other Current Assets	4.6	101.28	237.55	174.93	167.15	151.41
Total Current Assets	557.03	830.23	2,702	2,889	3,234	3,096
Property, Plant & Equipment	768.1	817.46	4,061	4,519	4,469	4,166
Long-Term Investments	8.83	29.42	197.39	151.07	237.7	439.13
Long-Term Deferred Tax Assets	16.07	17.69	11.63	0.05	0.05	0.05
Other Long-Term Assets	29.06	20.32	24.38	25.65	23.63	29.52
Total Assets	1,774	2,095	7,014	7,598	7,965	7,730
Accounts Payable	19.94	30.91	79.49	86.36	72.2	66.71
Short-Term Debt	-	184.75	608.69	570.26	162	135
Current Portion of Long-Term Debt	185.39	-	5.7	70	598.64	518.13
Current Portion of Leases	-	48.27	52.16	50.88	55.56	63.02
Current Income Taxes Payable	4.26	4.51	95.85	142.34	132.24	58.01
Current Unearned Revenue	10.43	12.02	175.87	242.97	596.57	548.83
Other Current Liabilities	139.52	100.41	639.43	718.5	754.19	483.98
Total Current Liabilities	359.53	380.87	1,657	1,881	2,371	1,874
Long-Term Debt	162.75	276.2	1,032	1,041	901.25	1,148
Long-Term Leases	52.64	50.85	65.61	72.17	53.09	78.42
Long-Term Deferred Tax Liabilities	0.65	1.36	569.38	642.3	685.44	633.92
Other Long-Term Liabilities	-	0.37	0.8	0.42	3	3.16
Total Liabilities	575.57	709.65	3,325	3,637	4,014	3,737
Common Stock	11.25	11.71	12.05	12.32	12.32	12.32
Additional Paid-In Capital	1,279	1,489	2,373	2,382	2,382	2,382
Retained Earnings	-56.77	-82.9	-108.78	-82.55	26.31	410.51
Comprehensive Income & Other	-33.15	-30.99	73.12	203.54	144.21	-162.53
Total Common Equity	1,200	1,387	2,349	2,516	2,565	2,643
Minority Interest	-1.45	-1.49	1,339	1,445	1,385	1,351
Shareholders' Equity	1,199	1,385	3,688	3,961	3,950	3,993
Total Liabilities & Equity	1,774	2,095	7,014	7,598	7,965	7,730
Total Debt	400.77	560.07	1,765	1,804	1,771	1,942
Net Cash (Debt)	-291.87	-368.22	-1,196	-1,174	-1,117	-1,368
Net Cash Per Share	-0.25	-0.31	-0.98	-0.95	-0.91	-1.11
Filing Date Shares Outstanding	1,125	1,125	1,205	1,232	1,232	1,232
Total Common Shares Outstanding	1,125	1,171	1,205	1,232	1,232	1,232
Working Capital	197.5	449.36	1,045	1,007	862.35	1,222
Book Value Per Share	1.07	1.18	1.95	2.04	2.08	2.15
Tangible Book Value	1,200	1,387	2,349	2,516	2,565	2,643
Tangible Book Value Per Share	1.07	1.18	1.95	2.04	2.08	2.15
Buildings	-	497.06	696.12	703.29	698.41	705.35
Machinery	-	155.26	216	211.59	197.5	182.12
Leasehold Improvements	-	83.18	89.17	94.39	93.67	78.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.